Literature DB >> 29288078

Immune mechanisms of oral immunotherapy.

Michael D Kulis1, Sarita U Patil2, Erik Wambre3, Brian P Vickery4.   

Abstract

Oral immunotherapy (OIT) has demonstrated reproducibly successful desensitization in patients with food allergy completing clinical trials and, in some studies, sustained unresponsiveness. These clinical outcomes have been associated with characteristic modifications in the allergen-specific immune response, but a detailed synthesis of OIT's mechanisms of action is lacking. In this rostrum we review the current evidence regarding the human immune response to OIT, explore possible mechanisms, and identify knowledge gaps for future research.
Copyright © 2017 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  B cells; Oral immunotherapy; T cells; antibodies; basophils; desensitization; immune mechanisms; mast cells; sustained unresponsiveness

Mesh：

Substances：

Year:  2017        PMID： 29288078      PMCID： PMC6939858          DOI： 10.1016/j.jaci.2017.12.979

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


  57 in total

1.  Oral immunotherapy for treatment of egg allergy in children.

Authors:  A Wesley Burks; Stacie M Jones; Robert A Wood; David M Fleischer; Scott H Sicherer; Robert W Lindblad; Donald Stablein; Alice K Henning; Brian P Vickery; Andrew H Liu; Amy M Scurlock; Wayne G Shreffler; Marshall Plaut; Hugh A Sampson
Journal:  N Engl J Med       Date:  2012-07-19       Impact factor: 91.245

2.  Novel baseline predictors of adverse events during oral immunotherapy in children with peanut allergy.

Authors:  Yamini V Virkud; A Wesley Burks; Pamela H Steele; Lloyd J Edwards; Jelena P Berglund; Stacie M Jones; Amy M Scurlock; Tamara T Perry; Robert D Pesek; Brian P Vickery
Journal:  J Allergy Clin Immunol       Date:  2016-09-05       Impact factor: 10.793

3.  IL-4 production by group 2 innate lymphoid cells promotes food allergy by blocking regulatory T-cell function.

Authors:  Magali Noval Rivas; Oliver T Burton; Hans C Oettgen; Talal Chatila
Journal:  J Allergy Clin Immunol       Date:  2016-04-18       Impact factor: 10.793

Review 4.  The atopic march: current insights into skin barrier dysfunction and epithelial cell-derived cytokines.

Authors:  Hongwei Han; Florence Roan; Steven F Ziegler
Journal:  Immunol Rev       Date:  2017-07       Impact factor: 12.988

5.  Exploiting CD22 on antigen-specific B cells to prevent allergy to the major peanut allergen Ara h 2.

Authors:  Kelly A Orgel; Shiteng Duan; Benjamin L Wright; Soheila J Maleki; John C Wolf; Brian P Vickery; A Wesley Burks; James C Paulson; Mike D Kulis; Matthew S Macauley
Journal:  J Allergy Clin Immunol       Date:  2016-08-20       Impact factor: 10.793

6.  Clinical efficacy and immune regulation with peanut oral immunotherapy.

Authors:  Stacie M Jones; Laurent Pons; Joseph L Roberts; Amy M Scurlock; Tamara T Perry; Mike Kulis; Wayne G Shreffler; Pamela Steele; Karen A Henry; Margaret Adair; James M Francis; Stephen Durham; Brian P Vickery; Xiaoping Zhong; A Wesley Burks
Journal:  J Allergy Clin Immunol       Date:  2009-07-03       Impact factor: 10.793

7.  Modulation of dendritic cell innate and adaptive immune functions by oral and sublingual immunotherapy.

Authors:  Pamela A Frischmeyer-Guerrerio; Corinne A Keet; Anthony L Guerrerio; Kristin L Chichester; Anja P Bieneman; Robert G Hamilton; Robert A Wood; John T Schroeder
Journal:  Clin Immunol       Date:  2014-08-27       Impact factor: 3.969

8.  Rapid desensitization induces internalization of antigen-specific IgE on mouse mast cells.

Authors:  Tatsuya Oka; Eon J Rios; Mindy Tsai; Janet Kalesnikoff; Stephen J Galli
Journal:  J Allergy Clin Immunol       Date:  2013-06-26       Impact factor: 10.793

9.  Basophil activation test discriminates between allergy and tolerance in peanut-sensitized children.

Authors:  Alexandra F Santos; Abdel Douiri; Natalia Bécares; Shih-Ying Wu; Alick Stephens; Suzana Radulovic; Susan M H Chan; Adam T Fox; George Du Toit; Victor Turcanu; Gideon Lack
Journal:  J Allergy Clin Immunol       Date:  2014-07-25       Impact factor: 10.793

10.  Single B-cell deconvolution of peanut-specific antibody responses in allergic patients.

Authors:  Ramona A Hoh; Shilpa A Joshi; Yi Liu; Chen Wang; Krishna M Roskin; Ji-Yeun Lee; Tho Pham; Tim J Looney; Katherine J L Jackson; Vaishali P Dixit; Jasmine King; Shu-Chen Lyu; Jennifer Jenks; Robert G Hamilton; Kari C Nadeau; Scott D Boyd
Journal:  J Allergy Clin Immunol       Date:  2015-07-04       Impact factor: 10.793
View more
  19 in total

1.  Sustained successful peanut oral immunotherapy associated with low basophil activation and peanut-specific IgE.

Authors:  Mindy Tsai; Kaori Mukai; R Sharon Chinthrajah; Kari C Nadeau; Stephen J Galli
Journal:  J Allergy Clin Immunol       Date:  2019-12-02       Impact factor: 10.793

Review 2.  The dilemma of open or double-blind food challenges in diagnosing food allergy in children: Design of the ALDORADO trial.

Authors:  Wouter W de Weger; Aline B Sprikkelman; Catherina E M Herpertz; Gerbrich N van der Meulen; Judith M Vonk; Arvid W A Kamps; Gerard H Koppelman
Journal:  Pediatr Allergy Immunol       Date:  2021-09-09       Impact factor: 5.464

3.  Early decrease in basophil sensitivity to Ara h 2 precedes sustained unresponsiveness after peanut oral immunotherapy.

Authors:  Sarita U Patil; Johanna Steinbrecher; Agustin Calatroni; Neal Smith; Alex Ma; Bert Ruiter; Yamini Virkud; Michael Schneider; Wayne G Shreffler
Journal:  J Allergy Clin Immunol       Date:  2019-08-01       Impact factor: 10.793

Review 4.  The Multifaceted B Cell Response in Allergen Immunotherapy.

Authors:  Rodrigo Jiménez-Saiz; Sarita U Patil
Journal:  Curr Allergy Asthma Rep       Date:  2018-10-05       Impact factor: 4.806

Review 5.  Dietary and Microbial Determinants in Food Allergy.

Authors:  Emmanuel Stephen-Victor; Elena Crestani; Talal A Chatila
Journal:  Immunity       Date:  2020-08-18       Impact factor: 31.745

6.  Immune changes beyond Th2 pathways during rapid multifood immunotherapy enabled with omalizumab.

Authors:  Monali Manohar; Diane Dunham; Sheena Gupta; Zheng Yan; Wenming Zhang; Samantha Minnicozzi; Matthew Kirkey; Bryan Bunning; Roshni Roy Chowdhury; Stephen J Galli; Scott D Boyd; Laurie Elizabeth Kost; R Sharon Chinthrajah; Manisha Desai; Hans C Oettgen; Holden T Maecker; Wong Yu; Rosemarie H DeKruyff; Sandra Andorf; Kari C Nadeau
Journal:  Allergy       Date:  2021-05-29       Impact factor: 14.710

Review 7.  Mechanisms of oral immunotherapy.

Authors:  Suzanne M Barshow; Michael D Kulis; A Wesley Burks; Edwin H Kim
Journal:  Clin Exp Allergy       Date:  2021-01-20       Impact factor: 5.401

8.  Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study.

Authors:  Stacie M Jones; Edwin H Kim; Kari C Nadeau; Anna Nowak-Wegrzyn; Robert A Wood; Hugh A Sampson; Amy M Scurlock; Sharon Chinthrajah; Julie Wang; Robert D Pesek; Sayantani B Sindher; Mike Kulis; Jacqueline Johnson; Katharine Spain; Denise C Babineau; Hyunsook Chin; Joy Laurienzo-Panza; Rachel Yan; David Larson; Tielin Qin; Don Whitehouse; Michelle L Sever; Srinath Sanda; Marshall Plaut; Lisa M Wheatley; A Wesley Burks
Journal:  Lancet       Date:  2022-01-22       Impact factor: 202.731

Review 9.  Plant cell-made protein antigens for induction of Oral tolerance.

Authors:  Henry Daniell; Michael Kulis; Roland W Herzog
Journal:  Biotechnol Adv       Date:  2019-06-26       Impact factor: 14.227

10.  Exploring novel systemic biomarker approaches in grass-pollen sublingual immunotherapy using omics.

Authors:  Tomas Clive Barker-Tejeda; Raphaelle Bazire; David Obeso; Leticia Mera-Berriatua; Domenico Rosace; Sonia Vazquez-Cortes; Tania Ramos; Maria Del Pilar Rico; Tomás Chivato; Coral Barbas; Alma Villaseñor; Maria M Escribese; Montserrat Fernández-Rivas; Carlos Blanco; Domingo Barber
Journal:  Allergy       Date:  2020-09-22       Impact factor: 13.146
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.